Asymchem Laboratories (Tianjin) Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Consun Pharmaceutical Group Ltd.

Tong Ren Tang Technologies Co., Ltd.

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

Asymchem Laboratories (Tianjin) Co., Ltd.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

Ocumension Therapeutics

3D Medicines, Inc.

Shanghai Junshi Biosciences Co., Ltd.

CARsgen Therapeutics Holdings Ltd.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Cutia Therapeutics

Why is Asymchem Laboratories (Tianjin) Co., Ltd. ?

High Debt company with Weak Long Term Fundamental Strength

With ROE of 5.91%, it has a Very Expensive valuation with a 0.13 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 40.45%, its profits have fallen by -3.7%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Asymchem Laboratories (Tianjin) Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Asymchem Laboratories (Tianjin) Co., Ltd.

40.45%

0.75

61.32%

Hang Seng Hong Kong

27.36%

1.06

25.88%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

17.01%

EBIT Growth (5y)

1.30%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.44

Sales to Capital Employed (avg)

0.48

Tax Ratio

13.90%

Dividend Payout Ratio

41.14%

Pledged Shares

Institutional Holding

ROCE (avg)

20.37%

ROE (avg)

11.88%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.13

EV to EBIT

-6.14

EV to EBITDA

-3.77

EV to Capital Employed

-0.55

EV to Sales

-0.85

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

5.91%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Asymchem Laboratories (Tianjin) Co., Ltd.

Operating Cash Flow - Annually

Highest at HKD 4,142.38 MM and Grown

each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Cash and Cash Equivalents - Half Yearly

Highest at HKD 7,828.13 MM

in the last six half yearly periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents (HKD MM)

Here's what is not working for Asymchem Laboratories (Tianjin) Co., Ltd.

Net Sales - Quarterly

At HKD 1,543 MM has Fallen at -36.6 %

over average Net Sales of the previous four periods of HKD 2,432 MM

MOJO Watch

Near term sales trend is very negative

Net Sales (HKD MM)

Profit Before Tax less Other Income (PBT) - Quarterly

At HKD 40 MM has Fallen at -94.6 %

over average PBT of the previous four periods of HKD 753 MM

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (HKD MM)

Profit After Tax (PAT) - Quarterly

At HKD 61 MM has Fallen at -91.9 %

over average PAT of the previous four periods of HKD 752 MM

MOJO Watch

Near term PAT trend is very negative

PAT (HKD MM)

Net Sales - Quarterly

Lowest at HKD 1,543 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (HKD MM)

Operating Profit (PBDIT) - Quarterly

Lowest at HKD 179 MM.

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (HKD MM)

Operating Profit Margin - Quarterly

Lowest at 11.61%

in the last five quarters

MOJO Watch

Company's efficiency has deteriorated

Operating Profit to Sales (HKD MM)

Profit Before Tax less Other Income (PBT) - Quarterly

Lowest at HKD 40 MM.

in the last five periods

MOJO Watch

Near term PBT trend is negative

PBT less Other Income (HKD MM)

Profit After Tax (PAT) - Quarterly

Lowest at HKD 61 MM.

in the last five periods

MOJO Watch

Near term PAT trend is negative

PAT (HKD MM)

Non Operating Income - Quarterly

is 63.44 % of Profit Before Tax (PBT)

MOJO Watch

The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT (HKD MM)

Earnings per Share (EPS) - Quarterly

Lowest at HKD 0.17

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (HKD)

Dividend Payout Ratio (DPR) - Annually

Lowest at 0.00 %

in the last five years

MOJO Watch

Company is distributing lower proportion of profits generated as dividend

DPR (%)